Clinical Trial Update: Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine [Phase 4]

View source ↗

Summary

This Phase 4 trial reports on long-term safety, immunogenicity, and lot-to-lot consistency for a liquid pentavalent vaccine covering diphtheria, tetanus, pertus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Infection
• Hepatitis B
• Pertussis
• Tetanus

Drugs mentioned

• Pentavalent vaccine (liquid) (pentavalent combination vaccine (Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus influenzae type b))

Snippet

Sponsor: Shantha Biotechnics Limited | Conditions: Diphtheria, Tetanus | Phase 4 | Status: UNKNOWN